Anti-angiogenic Drugs as an Adjunctive Therapy in the Surgical Treatment of Diabetic Retinopathy

E-ISSN： 1875-6417|5|1|52-56

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.5, Iss.1, 2009-02, pp. : 52-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy

Current Diabetes Reviews, Vol. 2, Iss. 1, 2006-02 ,pp. : 71-98

Bentham Science Publishers

Access to resources Recommend Favorite

Intravitreal Anti-VEGF Drugs as Adjuvant Therapy in Diabetic Retinopathy Surgery

Current Diabetes Reviews, Vol. 7, Iss. 3, 2011-05 ,pp. : 176-184

Bentham Science Publishers

Access to resources Recommend Favorite

Thromboembolic Events in Patients Treated with Anti-Angiogenic Drugs

Current Vascular Pharmacology, Vol. 8, Iss. 1, 2010-01 ,pp. : 102-113

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic Drugs in the Treatment of Metastatic Renal Cell Carcinoma: Advances in Clinical Application

Current Vascular Pharmacology, Vol. 13, Iss. 3, 2015-05 ,pp. : 381-391

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic therapy: Rationale, challenges and clinical studies

By Longo R. Sarmiento R. Fanelli M. Capaccetti B. Gattuso D. Gasparini G.

Angiogenesis, Vol. 5, Iss. 4, 2002-01 ,pp. : 237-256

Springer Publishing Company

Access to resources Recommend Favorite